课题基金 / 基金详情

Defining and targeting mechanisms of pancreas cancer pathogenesis

Defining and targeting mechanisms of pancreas cancer pathogenesis
胰腺癌发病机制的定义和靶向机制
批准号:
10603096
负责人:
Martin Whittle
金额:
$6.14万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-19 至 2022-08-31

项目摘要

项目成果

Martin Whittle的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
Project Summary Dr. Martin Whittle is a senior scientist working in the laboratory of Dr. Sunil Hingorani at the Fred Hutchinson Cancer Research Center. Dr. Whittle’s training has provided him a strong foundation in the fields of molecular biology, cancer cell signaling, and tumor modeling in mice. This Research Specialist award will support Dr. Whittle’s effort on research projects central to the overall Hingorani Laboratory research program including the following three key projects: the complex pancreas cancer microenvironment and its contributions to disease pathogenesis and drug resistance; the immune reaction in PDA and development of effective immunotherapies; and the molecular underpinnings of the metastatic switch in pancreas cancer. Aside from performing vital experiments for each of these projects, Dr. Whittle further supports the Hingorani lab by training new technicians and postdoctoral fellows in fundamental and advanced laboratory techniques that are critical to the Hingorani research program, including genetic engineering, mouse model development and characterization, animal husbandry, surgical procedures and necropsies, primary tissue culture, histochemistry and immunohistology, genotyping PCR, qRT-PCR, western blotting, FACS, fluorescence microscopy, gene array, molecular cloning, ELISA, mass spectrometry and others.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1097/ppo.0000000000000289
发表时间: 2017
期刊: Cancer journal (Sudbury, Mass.)
影响因子: --
作者: [Whittle MC, Hingorani SR]
通讯作者: Hingorani SR
Defining and targeting mechanisms of pancreas cancer pathogenesis
Defining and targeting mechanisms of pancreas cancer pathogenesis
Defining and targeting mechanisms of pancreas cancer pathogenesis
Defining mechanisms of MEK1/2 inhibitor response in triple negative breast cancer
国内基金
海外基金
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
诱导性多能干细胞rDNA区基因打靶在线粒体视神经病中的治疗研究
  • 批准号:
    81970829
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2019
  • 负责人:
    李卓
  • 依托单位:
Pre-targeting/Click反应介导的自体循环干细胞在心脏缺血损伤修复中的应用及机制研究
  • 批准号:
    81873493
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    沈德良
  • 依托单位:
以IGF2/IGF1R与SYT/SSX1为靶点治疗滑膜肉瘤的实验研究
  • 批准号:
    81102033
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2011
  • 负责人:
    李大森
  • 依托单位: